Skip to main content
Top
Published in: Endocrine Pathology 3/2008

01-09-2008

The Genomic Revolution and Endocrine Pathology

Authors: Suzana S. Couto, Robert D. Cardiff

Published in: Endocrine Pathology | Issue 3/2008

Login to get access

Abstract

The genome has been sequenced. However, the functions of each gene remain to be elucidated through phenotypic analysis. This analysis has been called phenogenomics. That part of phenogenomics related to disease can be called pathogenomics or Genomic Pathology. The initial phases of disease analysis will use genetically modified mice. The proliferation of ambitious programs designed to use mice for phenogenomics has been met with alarm by comparative pathologists who note the lack of qualified genomic pathologists and of training programs in genomic pathology. While endocrine pathology offers a number of excellent examples of the contributions made by pathologists to the scientific literature, it also contains examples of the hazards of working with untrained, unwary personnel.
Literature
3.
go back to reference Schwabe CW. Cattle, priests, and progress in medicine. Minneapolis: Univ. of Minnesota Press, 1978. Schwabe CW. Cattle, priests, and progress in medicine. Minneapolis: Univ. of Minnesota Press, 1978.
4.
go back to reference Schwabe CW. Veterinary medicine and human health. Baltimore: Williams and Wilkins, 1984. Schwabe CW. Veterinary medicine and human health. Baltimore: Williams and Wilkins, 1984.
6.
go back to reference Mahler JF, Stokes W, Mann PC, Takaoka M, Maronpot RR. Spontaneous lesions in aging FVB/N mice. Toxicol Pathol 24:710–716, 1996.PubMed Mahler JF, Stokes W, Mann PC, Takaoka M, Maronpot RR. Spontaneous lesions in aging FVB/N mice. Toxicol Pathol 24:710–716, 1996.PubMed
7.
go back to reference Nieto AI, Shyamala G, Galvez JJ, Thordarson G, Wakefield LM, Cardiff RD. Persistent mammary hyperplasia in FVB/N mice. Comp Med 53:433–438, 2003.PubMed Nieto AI, Shyamala G, Galvez JJ, Thordarson G, Wakefield LM, Cardiff RD. Persistent mammary hyperplasia in FVB/N mice. Comp Med 53:433–438, 2003.PubMed
8.
go back to reference Wakefield LM, Thordarson G, Nieto AI, et al. Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling. Comp Med 53:424–432, 2003.PubMed Wakefield LM, Thordarson G, Nieto AI, et al. Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling. Comp Med 53:424–432, 2003.PubMed
10.
go back to reference Borowsky AD, Dingley KH, Ubick E, Turteltaub KW, Cardiff RD, Devere-White R. Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model. Neoplasia 8:708–715, 2006. doi:10.1593/neo.06373.PubMedCrossRef Borowsky AD, Dingley KH, Ubick E, Turteltaub KW, Cardiff RD, Devere-White R. Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model. Neoplasia 8:708–715, 2006. doi:10.​1593/​neo.​06373.PubMedCrossRef
11.
12.
go back to reference Huss WJ, Gray DR, Tavakoli K, et al. Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model. Neoplasia 9:938–950, 2007. doi:10.1593/neo.07562.PubMedCrossRef Huss WJ, Gray DR, Tavakoli K, et al. Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model. Neoplasia 9:938–950, 2007. doi:10.​1593/​neo.​07562.PubMedCrossRef
15.
go back to reference Kasper S, Sheppard PC, Yan Y, et al. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. Lab Invest 78:319–333, 1998.PubMed Kasper S, Sheppard PC, Yan Y, et al. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. Lab Invest 78:319–333, 1998.PubMed
17.
go back to reference Shappell SB, Thomas GV, Roberts RL, et al. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 64:2270–2305, 2004. doi:10.1158/0008-5472.CAN-03-0946.PubMedCrossRef Shappell SB, Thomas GV, Roberts RL, et al. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 64:2270–2305, 2004. doi:10.​1158/​0008-5472.​CAN-03-0946.PubMedCrossRef
18.
19.
go back to reference Syder AJ, Karam SM, Mills JC, et al. A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype. Proc Natl Acad Sci U S A 101:4471–4476, 2004. doi:10.1073/pnas.0307983101.PubMedCrossRef Syder AJ, Karam SM, Mills JC, et al. A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype. Proc Natl Acad Sci U S A 101:4471–4476, 2004. doi:10.​1073/​pnas.​0307983101.PubMedCrossRef
20.
go back to reference Gum JR Jr., Hicks JW, Crawley SC, et al. Mice expressing SV40 T antigen directed by the intestinal trefoil factor promoter develop tumors resembling human small cell carcinoma of the colon. Mol Cancer Res 2:504–513, 2004.PubMed Gum JR Jr., Hicks JW, Crawley SC, et al. Mice expressing SV40 T antigen directed by the intestinal trefoil factor promoter develop tumors resembling human small cell carcinoma of the colon. Mol Cancer Res 2:504–513, 2004.PubMed
21.
22.
23.
go back to reference Wikenheiser KA, Clark JC, Linnoila RI, Stahlman MT, Whitsett JA. Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res 52:5342–5352, 1992.PubMed Wikenheiser KA, Clark JC, Linnoila RI, Stahlman MT, Whitsett JA. Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res 52:5342–5352, 1992.PubMed
25.
go back to reference Connolly DC, Bao R, Nikitin AY, et al. Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res 63:1389–1397, 2003.PubMed Connolly DC, Bao R, Nikitin AY, et al. Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res 63:1389–1397, 2003.PubMed
26.
go back to reference Green JE, Shibata MA, Yoshidome K, et al. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene 19:1020–1027, 2000. doi:10.1038/sj.onc.1203280.PubMedCrossRef Green JE, Shibata MA, Yoshidome K, et al. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene 19:1020–1027, 2000. doi:10.​1038/​sj.​onc.​1203280.PubMedCrossRef
27.
go back to reference Grippo PJ, Sandgren EP. Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model. Am J Pathol 157:805–813, 2000.PubMed Grippo PJ, Sandgren EP. Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model. Am J Pathol 157:805–813, 2000.PubMed
28.
go back to reference Ledent C, Dumont J, Vassart G, Parmentier M. Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice. Endocrinology 129:1391–1401, 1991.PubMedCrossRef Ledent C, Dumont J, Vassart G, Parmentier M. Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice. Endocrinology 129:1391–1401, 1991.PubMedCrossRef
29.
go back to reference Hu Y, Ippolito JE, Garabedian EM, Humphrey PA, Gordon JI. Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice. J Biol Chem 277:44462–44474, 2002. doi:10.1074/jbc.M205784200.PubMedCrossRef Hu Y, Ippolito JE, Garabedian EM, Humphrey PA, Gordon JI. Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice. J Biol Chem 277:44462–44474, 2002. doi:10.​1074/​jbc.​M205784200.PubMedCrossRef
32.
34.
go back to reference Stambolic V, Tsao MS, Macpherson D, Suzuki A, Chapman WB, Mak TW. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/− mice. Cancer Res 60:3605–3611, 2000.PubMed Stambolic V, Tsao MS, Macpherson D, Suzuki A, Chapman WB, Mak TW. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/− mice. Cancer Res 60:3605–3611, 2000.PubMed
35.
go back to reference Tischler AS, Shih TS, Williams BO, Jacks T. Characterization of pheochromocytomas in a mouse strain with a targeted disruptive mutation of the neurofibromatosis gene Nf1. Endocr Pathol 6:323–335, 1995. doi:10.1007/BF02738732.PubMedCrossRef Tischler AS, Shih TS, Williams BO, Jacks T. Characterization of pheochromocytomas in a mouse strain with a targeted disruptive mutation of the neurofibromatosis gene Nf1. Endocr Pathol 6:323–335, 1995. doi:10.​1007/​BF02738732.PubMedCrossRef
37.
go back to reference Barthold SW, Borowsky AD, Brayton C, et al. From whence will they come? - A perspective on the acute shortage of pathologists in biomedical research. J Vet Diagn Invest 19:455–456, 2007.PubMed Barthold SW, Borowsky AD, Brayton C, et al. From whence will they come? - A perspective on the acute shortage of pathologists in biomedical research. J Vet Diagn Invest 19:455–456, 2007.PubMed
39.
go back to reference Valli T, Barthold SW, Ward JE, et al. Over 60% of NIH extramural funding involves animal-related research. Vet Pathol 44:962–963, 2007, (author reply 963–964).PubMedCrossRef Valli T, Barthold SW, Ward JE, et al. Over 60% of NIH extramural funding involves animal-related research. Vet Pathol 44:962–963, 2007, (author reply 963–964).PubMedCrossRef
Metadata
Title
The Genomic Revolution and Endocrine Pathology
Authors
Suzana S. Couto
Robert D. Cardiff
Publication date
01-09-2008
Publisher
Humana Press Inc
Published in
Endocrine Pathology / Issue 3/2008
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-008-9042-2

Other articles of this Issue 3/2008

Endocrine Pathology 3/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.